NEW YORK / Jan 25, 2023 / Business Wire / MultiPlan Corporation (NYSE:MPLN), a leading provider of data analytics and technology-enabled cost management, payment and revenue integrity services to the U.S. healthcare industry, is pleased to announce that Carol Nutter has joined the company as Chief People Officer.
In her new role, Carol will oversee the people strategy and operations of recruitment, talent management, employee engagement and wellness, DEIB (diversity, equity, inclusion, and belonging), and building development opportunities for upskilling and reskilling. She reports to Dale White, Chief Executive Officer.
“It’s my pleasure to welcome Carol to the team,” said Mr. White. “I look forward to benefitting from her expertise as we continue to attract and retain best-in-class talent who deliver service excellence to MultiPlan’s broad base of customers, providers and other constituents.”
Carol has over 20 years of experience developing, implementing and leading people strategies across a diverse portfolio of companies and industries. Prior to joining MultiPlan, she served as the Senior Vice President of Talent and Culture at Optoro, where she led employee acquisition and retention initiatives that helped the company scale effectively during a time of significant growth.
“I am thrilled to be joining MultiPlan as its Chief People Officer,” commented Carol. “MultiPlan has an impressive 40 year history of trailblazing and creating outstanding opportunities for great employees to do great work. I’m excited to partner with our people and leaders to build on this foundation and continue to propel the Company forward”.
MultiPlan earned the Great Places to Work Certification for 2022-2023, with over 85 percent of surveyed employees expressing satisfaction with the Company. The Company currently employs over 2,500 people.
About MultiPlan
MultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics and a team rich with industry experience, MultiPlan interprets clients’ needs and customizes innovative solutions that combine its payment integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, government, property and casualty and dental markets. For more information, visit www.multiplan.com.
Last Trade: | US$14.26 |
Daily Change: | -0.52 -3.52 |
Daily Volume: | 13,643 |
Market Cap: | US$230.580M |
December 24, 2024 November 05, 2024 October 03, 2024 May 08, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB